Search Results 41-50 of 19457 for Alzheimer's disease
A new report identifies national research priorities for Alzheimer's disease and related dementias over the next decade.
The Alzheimer's Association estimates that 5.2 million Americans are living with AD. And with nearly half of hippocampal sparing AD patients being misdiagnosed, ...
Clinical/cognitive, imaging, biomarker, and genetic characteristics will be assessed across three cohorts: (1) early onset Alzheimer's Disease (EOAD) ...
But FTD tends to occur at a younger age than does Alzheimer's disease. It often begins between the ages of 40 and 65, although it can occur later in life as ...
Researchers in this brain focus area of the Discovery and Translation Labs at Mayo Clinic study Alzheimer's disease and related dementias, seeking genetic ...
Alzheimer's disease brain pathology is illustrated using thioflavin-S fluorescent microscopy, which reveals both neurofibrillary tangles (flame-shaped ...
Lecanemab (Leqembi) is a medicine given to slow the progression of mild Alzheimer's disease (AD). This medicine reduces clumps of proteins called amyloid-beta ...
Understand more about this brain disease that is the most common cause of dementia. Also learn about new tests and medicines.
The Alzheimer's Association leads the way to end Alzheimer's disease and all other dementias by accelerating global research, driving risk reduction and early ...
Aging is associated with a loss of brain function and conditions such as dementia and Alzheimer's disease. It is likely that decreased brain metabolism is ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Give by Dec. 31 to multiply your impact 3×.